Combinatorial experimental protocols for Erbicin-derived immunoagents and Herceptin

This publication has 54 references indexed in Scilit:

• Generation of a non-small cell lung cancer transcriptome microarray
  BMC Medical Genomics, 2008
• Amplification biases: possible differences among deviating gene expressions
  BMC Genomics, 2008
• Optimization of laser capture microdissection and RNA amplification for gene expression profiling of prostate cancer
  BMC Molecular Biology, 2007
• Characterization of a method for profiling gene expression in cells recovered from intact human prostate tissue using RNA linear amplification
  Prostate Cancer and Prostatic Diseases, 2006
• Novel Isothermal, Linear Nucleic Acid Amplification Systems for Highly Multiplexed Applications
  Clinical Chemistry, 2005
• Biological properties of a human compact anti-ErbB2 antibody
  Carcinogenesis: Integrative Cancer Research, 2005
• Microarray-based comparison of three amplification methods for nanogram amounts of total RNA
  American Journal of Physiology-Cell Physiology, 2005
• Reliability of T7-Based mRNA Linear Amplification Validated by Gene Expression Analysis of Human Kidney Cells Using cDNA Microarrays
  Nephron Experimental Nephrology, 2004
• In vitro comparative evaluation of trastuzumab (Herceptin®) combined with paclitaxel (Taxol®) or docetaxel (Taxotere®) in HER2-expressing human breast cancer cell lines
  Annals of Oncology, 2002
• A subclass of tumor-inhibitory monoclonal antibodies to ErbB-2/HER2 blocks crosstalk with growth factor receptors
  Oncogene, 1997